These results revealed that Merlin negatively regulated the expression and activation of TAZ via the Hippo pathway and that elevated expression and activation of TAZ in pancreatic cancer cases may result from decreased expression of Merlin. The gene discussed is WWTR1; the disease is pancreatic neoplasm.